trial · primary record
Standard Dose Quadrivalent Inactivated Influenza Vaccine
Immunization; Infection
| Phase | Phase 2 |
|---|---|
| Status | RECRUITING |
| Sponsor | Unknown |
| Enrolment | 312 |
| Primary completion | 2027-09-01 |
| Primary endpoint | Immunogenicity: Hemagglutination Inhibition (HAI) titers |
| Registry ID | NCT05947071 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-10-28T13:41:38.765Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT05947071
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.